Sanofi has officially opened its new $130 million flagship corporate offices in Morristown, New Jersey. The move consolidates nearly 2,000 employees in a 260,000-square-foot facility designed to accelerate the company’s commercial operations and strategic decision-making in its largest market. The facility replaces Sanofi’s older Bridgewater operations about 19 miles away. The opening of the new facilities reflects the latest phase of the French pharma giant’s $20 billion-plus U.S. investment commitment through 2030, announced earlier this month.
The Morristown hub primarily houses corporate functions including senior leadership for Sanofi North America, marketing and sales operations, regulatory affairs, medical affairs, and business management teams. The new offices are a commercial counterpart to Sanofi’s R&D-focused Cambridge, Massachusetts campus that opened in 2022.
The U.S. represents Sanofi’s largest single market, accounting for 47% of its pharmaceutical sales in the first quarter of 2025.
The Morristown facility will be the home base for employees across a variety of role types, including corporate leadership, marketing/sales operations, regulatory affairs, medical affairs, and business management.
M Station West is the specific building Sanofi occupies (260,000 sq ft, seven floors). [Image: SJP Properties]
The brochure for the M Station site notes it is the “first new office development in almost 40 years” in Morristown. The location is transit-oriented, located directly across from Morristown Train Station with direct service to NYC Penn Station.
The facility features flexible workspaces, digitally enabled smart design, and amenities including wellness rooms, a public restaurant, and what the company calls the largest outdoor terrace space in New Jersey.
The building will achieve LEED Gold certification and WELL Gold Building standards, using about 28% less energy and reducing greenhouse gas emissions by more than 24% compared to standard office spaces.
CEO Paul Hudson described Sanofi as “an intrinsic part of the healthcare ecosystem of the United States.” New Jersey Governor Phil Murphy called the investment a “significant vote of confidence” in New Jersey.
Filed Under: Pharma 50
